These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1288361)

  • 21. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease.
    Wolfe MS; Xia W; Moore CL; Leatherwood DD; Ostaszewski B; Rahmati T; Donkor IO; Selkoe DJ
    Biochemistry; 1999 Apr; 38(15):4720-7. PubMed ID: 10200159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of neuronal cells and astrocytes by protease nexin-1 and thrombin.
    Cunningham DD
    Ann N Y Acad Sci; 1992 Dec; 674():228-36. PubMed ID: 1288365
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of beta-amyloid in the development of Alzheimer's disease.
    Ii K
    Drugs Aging; 1995 Aug; 7(2):97-109. PubMed ID: 7579788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling Alzheimer's. Scientists are close to figuring out how the disorder destroys brains. But will their knowledge save lives?
    Gorman C
    Time; 2000 Jul; 156(2):98-9. PubMed ID: 10977415
    [No Abstract]   [Full Text] [Related]  

  • 25. Design of a new protease inhibitor by the manipulation of the bait region of alpha 2-macroglobulin: inhibition of the tobacco etch virus protease by mutant alpha 2-macroglobulin.
    Van Rompaey L; Proost P; Van den Berghe H; Marynen P
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):191-5. PubMed ID: 7492312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An empirical model of gamma-secretase activity.
    Murphy MP; Wang R; Fraser PE; Fauq A; Golde TE
    Ann N Y Acad Sci; 2000; 920():233-40. PubMed ID: 11193156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New therapies. New Alzheimer's treatments that may ease the mind.
    Helmuth L
    Science; 2002 Aug; 297(5585):1260-2. PubMed ID: 12193764
    [No Abstract]   [Full Text] [Related]  

  • 29. Nucleotide and deduced amino acid sequence of an aspartic proteinase inhibitor homologue from potato tubers (Solanum tuberosum L.).
    Strukelj B; Pungercar J; Ritonja A; Krizaj I; Gubensek F; Kregar I; Turk V
    Nucleic Acids Res; 1990 Aug; 18(15):4605. PubMed ID: 2201952
    [No Abstract]   [Full Text] [Related]  

  • 30. Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application.
    Pietrzik C; Behl C
    Int J Exp Pathol; 2005 Jun; 86(3):173-85. PubMed ID: 15910551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of intracellular regulation of thiol proteinase inhibitors.
    Katunuma N; Kominami E
    Curr Top Cell Regul; 1985; 27():345-60. PubMed ID: 3912118
    [No Abstract]   [Full Text] [Related]  

  • 32. A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease.
    Small DH; Moir RD; Fuller SJ; Michaelson S; Bush AI; Li QX; Milward E; Hilbich C; Weidemann A; Beyreuther K
    Biochemistry; 1991 Nov; 30(44):10795-9. PubMed ID: 1718425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of prenylated protein endoprotease.
    Gilbert BA; Ma YT; Rando RR
    Methods Enzymol; 1995; 250():206-15. PubMed ID: 7651151
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of proteases during apoptosis.
    Patel T; Gores GJ; Kaufmann SH
    FASEB J; 1996 Apr; 10(5):587-97. PubMed ID: 8621058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of proteins in the membrane-cytoskeleton complex in Alzheimer's disease. Might amyloidogenic APP processing be just the tip of the iceberg?
    Saitoh T; Masliah E; Baum L; Sundsmo M; Flanagan L; Vikramkumar R; Kay MM
    Ann N Y Acad Sci; 1992 Dec; 674():180-92. PubMed ID: 1288363
    [No Abstract]   [Full Text] [Related]  

  • 36. Searching for the most effective screening system to identify cell-active inhibitors of beta-secretase.
    Middendorp O; Lüthi U; Hausch F; Barberis A
    Biol Chem; 2004 Jun; 385(6):481-5. PubMed ID: 15255179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple immunoassay to detect protease inhibitors in microbial fermentation broths.
    Carrano L; Guindani A; Denaro M; Islam K
    J Antibiot (Tokyo); 1995 Dec; 48(12):1511-4. PubMed ID: 8557613
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of tetramic and tetronic acids as beta-secretase inhibitors.
    Larbig G; Schmidt B
    J Comb Chem; 2006; 8(4):480-90. PubMed ID: 16827559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling of substrate specificity of the Alzheimer's disease amyloid precursor protein beta-secretase.
    Sauder JM; Arthur JW; Dunbrack RL
    J Mol Biol; 2000 Jul; 300(2):241-8. PubMed ID: 10873463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The involvement of amyloid associated proteins in the formation of beta-protein filaments in Alzheimer's disease.
    Potter H; Ma J; Das S; Kayyali U
    Prog Clin Biol Res; 1994; 390():57-71. PubMed ID: 7724651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.